M&A Deal Summary

ETST Acquires BEO STIs

On June 20, 2016, ETST acquired medical products company BEO STIs

Acquisition Highlights
  • This is ETST’s 1st transaction in the Medical Products sector.
  • This is ETST’s 1st transaction in Canada.
  • This is ETST’s 1st transaction in Quebec.

M&A Deal Summary
Date 2016-06-20
Target BEO STIs
Sector Medical Products
Buyer(s) ETST
Deal Type Add-on Acquisition

Target

BEO STIs

Quebec City, Quebec, Canada
BEO STIs, Inc. is a Canadian Biotech Company engaged in the development of medical devices, testing processes, and vaccines for STIs (Sexually Transmitted Infections and/or Diseases).

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

ETST

Doral, Florida, United States
Category Company
Founded 2010
Sector Life Science
Employees3
DESCRIPTION

ETST is a unique Science based Biotechnology company focused on cutting edge Nutraceuticals, Bioceuticals, Phytoceuticals and Cosmeceuticals for the Health, Wellness and Alternative Medicine Markets and to improving the quality of life for Consumers Worldwide. ETST is also dedicated to providing Natural Alternatives to prescription medications through Nutritional Supplements and Dietary Supplements that help improve common disorders and illnesses. This may include products such as CBD (Cannabidiol) as a natural constituent of Hemp Oil, Vitamins, Minerals, Herbs, Botanicals, Personal Care Products, Homeopathies, Functional Foods and other products. ETST was founded in 2010 and is based in Doral, Florida.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Quebec) 1 of 1
Country (Canada) 1 of 1
Year (2016) 1 of 1
Mergr

Product

Company

Legal